Analyst Price Target is $9.33
▼ -37.82% Downside Potential
This price target is based on 5 analysts offering 12 month price targets for Tempest Therapeutics in the last 3 months. The average price target is $9.33, with a high forecast of $23.00 and a low forecast of $2.00. The average price target represents a -37.82% upside from the last price of $15.01.
Current Consensus is
The current consensus among 5 contributing investment analysts is to hold stock in Tempest Therapeutics. This rating has held steady since August 2020, when it changed from a Buy consensus rating.